-92.5%
ENPH vs SBAC
-44.7%
-47.8%
-94.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | SBAC | Excess | Alpha |
|---|---|---|---|---|
| 1D | -10.7% | +2.2% | -12.9% | -11.6% |
| 7D | -24.7% | -8.5% | -16.2% | -21.8% |
| 30D | -38.6% | +0.6% | -39.3% | -38.8% |
| 3M | -48.8% | -3.4% | -45.5% | -48.3% |
| 6M | -63.1% | -14.9% | -48.1% | -61.0% |
| YTD | -38.8% | -8.0% | -30.7% | -40.0% |
| 1Y | -24.8% | -8.9% | -16.0% | -26.0% |
| 3Y | -80.1% | -21.3% | -58.7% | -78.6% |
| All | -92.5% | -44.7% | -47.8% | -90.0% |
Cumulative growth
Daily Returns
Daily percentage return beside SBAC.
Daily Out/Under-Performance
Portfolio return minus SBAC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × SBAC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded SBAC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling